| Biomarker ID | 65 |
| PMID | 15666362 |
| Year | 2005 |
| Biomarker | Proliferating cell nuclear antigen (PCNA) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Mice |
| Regulation | Upregulated in PCa (1.44 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:-Base excision repair, Global genomic nucleotide excision repair (,E2F-mediated regulation of DNA replicationGG-NER), DNA strand elongation,BARD1 signaling events |
| Experiment | Wild-type mouse dorsal prostate Vs Transgenic Adenocarcinoma Mouse Prostate (TRAMP) dorsal prostate |
| Type of Biomarker | Diagnostic |
| Cohort | Prostate tissues from TRAMP F1 mice (TG) and wild-type mice (WT) were used in this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | 2DIGE (2D-gel Electrophoresis) |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on human patient cohort |
| Technical Name | PCNA |